Medicare Enrolled
Dr. Edward Sanchez, M.D.
Surgery · Shenandoah, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sanchez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sanchez? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sanchez
Dr. Edward Sanchez is a surgery in Shenandoah, TX, with 13 years in practice. Based on federal Medicare data, Dr. Sanchez performed 5,550 Medicare services across 2,271 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sanchez received a total of $10,198 from 59 pharmaceutical and/or device companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sanchez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 1% volume in TX$ $10,198 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,550
Medicare services
Top 1% in TX for surgery
2,271
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~427 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,600 | $0 | $3 |
| Automated urinalysis | 825 | $2 | $16 |
| Office visit, established patient (30-39 min) | 674 | $89 | $368 |
| Infectious disease DNA/RNA test | 546 | $34 | $166 |
| Bladder ultrasound after voiding | 468 | $7 | $97 |
| Office visit, established patient (20-29 min) | 195 | $63 | $250 |
| New patient office visit (45-59 min) | 152 | $110 | $565 |
| Diagnostic exam of bladder and urethra using an endoscope | 130 | $170 | $684 |
| Detection test by nucleic acid for organism, quantification | 126 | $42 | $222 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 86 | $292 | $2,762 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 80 | $674 | $3,366 |
| Initial hospital admission, moderate complexity | 58 | $99 | $470 |
| Simple bladder irrigation and/or instillation | 42 | $50 | $296 |
| Yeast/candida DNA test | 42 | $34 | $123 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 42 | $34 | $182 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 42 | $34 | $153 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 42 | $34 | $153 |
| Detection test by nucleic acid for strep (streptococcus, group a), quantification | 42 | $41 | $146 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 42 | $34 | $123 |
| Hospital follow-up visit, moderate complexity | 33 | $60 | $247 |
| Detection test for gardnerella vaginalis (bacteria), quantification | 31 | $41 | $146 |
| Electronic assessment of bladder emptying | 24 | $6 | $277 |
| Assessment of muscle signal of pelvic nerves | 24 | $108 | $747 |
| Insertion of device into abdomen with pressure and urine flow rate study | 23 | $153 | $522 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 22 | $305 | $1,205 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 16 | $239 | $889 |
| Insertion of sacral nerve neurostimulator electrode array | 16 | $874 | $7,380 |
| New patient office visit (30-44 min) | 16 | $77 | $372 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $17 | $68 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 15 | $988 | $4,403 |
| Insertion of peripheral or gastric neurostimulator generator | 14 | $63 | $1,176 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $19 | $61 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 14 | $32 | $221 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 13 | $330 | $1,370 |
| Ceftriaxone antibiotic injection | 13 | $0 | $36 |
| CT scan of abdomen and pelvis with contrast | 12 | $173 | $1,067 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
38.0% medium
61.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,198
Total received (2018-2024)
Avg $1,457/year across 7 years
Top 27% in TX for surgery
59
Companies
296
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,941 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,909
2023$3,073
2022$1,906
2021$753
2020$156
2019$1,494
2018$907
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$1,563
Boston Scientific Corporation
$1,265
Myriad Genetic Laboratories, Inc.
$877
Coloplast Corp
$496
Cook Medical LLC
$441
Olympus America Inc.
$337
Janssen Biotech, Inc.
$337
BIOTISSUE HOLDINGS INC.
$295
BOSTON SCIENTIFIC CORPORATION
$289
ACCORD HEALTHCARE, INC.
$231
Endo Pharmaceuticals Inc.
$226
Teleflex LLC
$224
Sumitomo Pharma America, Inc.
$218
Antares Pharma, Inc.
$202
ABBVIE INC.
$178
Medtronic, Inc.
$176
PFIZER INC.
$171
Endo USA, Inc.
$161
UROVANT SCIENCES INC
$160
Palette Life Sciences, Inc.
$158
Agiliti Surgical, Inc.
$149
AbbVie Inc.
$138
Astellas Pharma US Inc
$133
Progenics Pharmaceuticals, Inc.
$132
Janssen Pharmaceuticals, Inc
$128
PROCEPT BioRobotics Corporation
$126
Laborie Medical Technologies Corp.
$124
180 Medical, Inc.
$114
Merck Sharp & Dohme Corporation
$94
GlaxoSmithKline, LLC.
$89
ConvaTec Inc.
$84
AstraZeneca Pharmaceuticals LP
$69
Abbott Laboratories
$64
ROCHESTER MEDICAL CORPORATION
$55
Bayer Healthcare Pharmaceuticals Inc.
$53
Shire North American Group Inc
$46
Tolmar, Inc.
$45
SANOFI PASTEUR INC.
$44
C. R. Bard, Inc. & Subsidiaries
$39
KARL STORZ Endoscopy-America
$38
Telix Pharmaceuticals
$38
Clarus Therapeutics Inc.
$35
Bard Peripheral Vascular, Inc.
$34
Blue Earth Diagnostics Limited
$28
Myovant Sciences Inc.
$26
Novartis Pharmaceuticals Corporation
$26
Ferring Pharmaceuticals Inc.
$24
Supernus Pharmaceuticals, Inc.
$23
COLOPLAST CORP
$23
Celgene Corporation
$23
Novo Nordisk Inc
$22
Amgen Inc.
$21
UroGen Pharma, Inc.
$18
Corcept Therapeutics
$18
TOLMAR Pharmaceuticals, Inc.
$17
Allergan, Inc.
$15
Calyxo, Inc.
$13
Allergan Inc.
$13
EDAP TECHNOMED INC
$11
Top 3 companies account for 36.3% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Altis · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACAnalysis · BRACAnalysis CDx · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CATHETER · CLINICAL TRIAL PRODUCT · COOK MEDICAL NCIRCLE · COOK MEDICAL STENTS · COOK MEDICAL WIRE GUIDES · CVAC ASPIRATION SYSTEM · Cook Medical Urology · ELIGARD · ERLEADA · FARXIGA · FLUZONE HIGH-DOSE · FreeStyle Libre blood glucose Flash Monitoring System · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL FEMALE SUI · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · ILLUCCIX · IMAGE1 X-LINK · INTERSTIM · JANUVIA · JATENZO · JELMYTO · Korlym · LithoVue · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · Olympus Laser Devices · Ozempic · PLUVICTO · POSLUMA · PROCLAIM · PROLARIS · PYLARIFY · Porges Coloplast · Prolaris · RESONATE EL ICD VR · Repatha · Rezum Generator · SIMPONI ARIA · STEGLATRO · STELARA · SpaceOAR VUE System - 10mL · SpeediCath · TACTRA · TLANDO · TORNADO · TRELEGY ELLIPTA · UGN Laser Capital · UROLIFT · UroLift 2 System · UroLift System · WATCHMAN Access System · XARELTO · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System · n.a.
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $184 per 100 Medicare services performed
Geographic Context
Surgerys within 10 mi
105
Per 100K population
16.0
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sanchez is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sanchez experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Sanchez performed 1,600 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sanchez receive payments from pharmaceutical companies?
Yes. Dr. Sanchez received a total of $10,198 from 59 companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sanchez's costs compare to other surgerys in Shenandoah?
Dr. Sanchez's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sanchez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerys in Shenandoah
Browse surgerys in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Surgerys in TX
Surgerys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerys in TX
Which TX surgerys receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology